JP Morgan Chase’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.8M Sell
559,586
-27,243
-5% -$1.54M ﹤0.01% 1610
2025
Q4
$24.4M Buy
586,829
+358,950
+158% +$14.9M ﹤0.01% 1892
2025
Q3
$9.18M Buy
227,879
+173,785
+321% +$5.05M ﹤0.01% 2797
2025
Q2
$1.41M Sell
54,094
-68,088
-56% -$1.64M ﹤0.01% 4162
2025
Q1
$2.99M Sell
122,182
-46,684
-28% -$1.31M ﹤0.01% 3574
2024
Q4
$4.84M Buy
168,866
+137,795
+443% +$4.71M ﹤0.01% 3373
2024
Q3
$1.17M Buy
31,071
+11,542
+59% +$405K ﹤0.01% 4367
2024
Q2
$617K Buy
19,529
+9,991
+105% +$346K ﹤0.01% 4564
2024
Q1
$419K Buy
+9,538
New +$390K ﹤0.01% 4905

Other funds holding CGON